Breaking News, Collaborations & Alliances

Aurigene & Edity Enter Strategic Collaboration in Cell Therapy

Aurigene will provide discovery services to Edity to support its clinical development.

Author Image

By: Charlie Sternberg

Associate Editor

Aurigene Pharmaceutical Services Limited, a global contract research, development, and manufacturing services organization (CRDMO), will provide discovery services to biotechnology company Edity Therapeutics Limited (Edity) in cell therapy. This news comes after Dr. Reddy’s Laboratories Limited, Aurigene’s parent company, recently made a strategic investment in Edity. Edity has developed an immune cell delivery platform to enable the selective delivery of intracellular therapeutic protei...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters